{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:52:12Z","timestamp":1790077932097,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpb.2025.114810","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:13:07Z","timestamp":1752642787000},"page":"114810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluating the efficacy of nintedanib-invasomes as a therapy for non-small cell lung cancer"],"prefix":"10.1016","volume":"214","author":[{"given":"Tamer Mohamed","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"AbdElrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Eskander","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Nagib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr Gamal","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Belal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisreen Khalid","family":"Aref Albezrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatha Hallal","family":"Al-Ziyadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif Faysal","family":"Abdelfattah Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Girgis","family":"Shahataa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0005","first-page":"335","article-title":"Lung cancer: epidemiology and screening","volume":"102","author":"Oliver","year":"2022","journal-title":"Surg. Clin."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114810_b0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/wo.2021.103829","article-title":"Epidemiology of lung cancer","volume":"25","author":"Thandra","year":"2021","journal-title":"Contempor. Oncol.\/wsp\u00f3\u0142czesna Onkol."},{"key":"10.1016\/j.ejpb.2025.114810_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1086214","article-title":"Efficacy and safety of nintedanib in patients with non-small cell lung cancer, and novel insights in radiation-induced lung toxicity","volume":"13","author":"Yan","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114810_b0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1753465815579608","article-title":"Nintedanib in non-small cell lung cancer: from preclinical to approval","volume":"9","author":"Caglevic","year":"2015","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1470-2045(13)70586-2","article-title":"Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial","volume":"15","author":"Reck","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejpb.2025.114810_b0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lungcan.2016.10.011","article-title":"Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): a randomized, double-blind, phase III trial","volume":"102","author":"Hanna","year":"2016","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114810_b0035","first-page":"316","article-title":"Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation reporta","volume":"40","author":"Bosch","year":"2016","journal-title":"Farm. Hospital."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2478\/raon-2023-0040","article-title":"Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis","volume":"57","author":"Ljubicic","year":"2023","journal-title":"Radiol. Oncol."},{"issue":"13","key":"10.1016\/j.ejpb.2025.114810_b0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2217\/nnm-2022-0045","article-title":"Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer","volume":"17","author":"Shukla","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2025.114810_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123644","article-title":"Nintedanib solid lipid nanoparticles improve oral bioavailability and ameliorate pulmonary fibrosis in vitro and in vivo models","volume":"649","author":"Kaur","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114810_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119569","article-title":"Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption","volume":"586","author":"Zhu","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114810_b0060","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.2147\/IJN.S181002","article-title":"A high bioavailability and sustained-release nano-delivery system for nintedanib based on electrospray technology","author":"Liu","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10401","article-title":"Development of nintedanib nanosuspension for inhaled treatment of experimental silicosis","volume":"8","author":"Andrade da Silva","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ejpb.2025.114810_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105340","article-title":"Development and characterization of nintedanib inhalable powders as a potential pulmonary fibrosis treatment","volume":"92","author":"Ruggiero","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114810_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102298","article-title":"Nebulized inhalation of nintedanib-loaded biomimetic nano-liposomes attenuated bleomycin-induced interstitial lung fibrosis in mice","volume":"56","author":"Rao","year":"2024","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114810_b0080","first-page":"110","article-title":"Nasal drug delivery systems: an overview","volume":"3","author":"Ghori","year":"2015","journal-title":"Am. J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s13346-023-01412-w","article-title":"Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis","volume":"14","author":"Fouad","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114810_b0090","article-title":"In vitro and in vivo evaluation of isoxsuprine loaded invasomes for efficient treatment of diabetes\u2010accelerated atherosclerosis","volume":"96","author":"Abou-Taleb","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0095","first-page":"194","article-title":"A review on factors affecting the design of nasal drug delivery system","volume":"3","author":"Dhakar","year":"2011","journal-title":"Int. J. Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114810_b0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijbiomac.2019.02.005","article-title":"Chitosan coated human serum albumin nanoparticles: a promising strategy for nose-to-brain drug delivery","volume":"129","author":"Piazzini","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0105","article-title":"Nasal cavity, a promising transmucosal platform for drug delivery and research approaches from nasal to brain targetting","volume":"2","author":"Singh","year":"2012","journal-title":"J. Drug Deliv. Therapeut."},{"key":"10.1016\/j.ejpb.2025.114810_b0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.reactfunctpolym.2016.01.011","article-title":"Mucoadhesion: a promising approach in drug delivery system","volume":"100","author":"Mansuri","year":"2016","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.ejpb.2025.114810_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.102166","article-title":"Invasomes: potential vesicular systems for transdermal delivery of drug molecules","volume":"61","author":"Jain","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/ph15020126","article-title":"Enhancing the bioavailability and efficacy of Vismodegib for the control of skin cancer: in vitro and in vivo studies","volume":"15","author":"Salem","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114810_b0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0975-8453.135837","article-title":"Invasomes-novel vesicular carriers for enhanced skin permeation","volume":"4","author":"Lakshmi","year":"2013","journal-title":"Syst. Rev. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114810_b0130","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/10717544.2022.2100514","article-title":"Utilization of propranolol hydrochloride mucoadhesive invasomes as a locally acting contraceptive: In-vitro, ex-vivo, and in-vivo evaluation","volume":"29","author":"Teaima","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2025.114810_b0135","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.2147\/IJN.S283911","article-title":"Low-frequency versus high-frequency ultrasound-mediated transdermal delivery of agomelatine-loaded invasomes: development, optimization and in-vivo pharmacokinetic assessment","author":"Tawfik","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/nano10020341","article-title":"Invasome: a novel nanocarrier for transdermal drug delivery","volume":"10","author":"Babaie","year":"2020","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0145","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/microorganisms11030733","article-title":"Synthesis of carvacrol-loaded invasomes nanoparticles improved acaricide efficacy, cuticle invasion and inhibition of acetylcholinestrase against hard ticks","volume":"11","author":"Gamal","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114810_b0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/2468187312666220513113117","article-title":"Formulation and evaluation of naproxen sodium loaded invasomes for topical delivery","volume":"12","author":"Shailaja","year":"2022","journal-title":"Curr. Nanomed. (Formerly: Recent Patents Nanomed.)"},{"issue":"7","key":"10.1016\/j.ejpb.2025.114810_b0155","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/molecules23071578","article-title":"Curcumin-loaded solid lipid nanoparticles enhanced anticancer efficiency in breast cancer","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114810_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2007.12.013","article-title":"Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies","volume":"127","author":"Dragicevic-Curic","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114810_b0165","unstructured":"Njoku CN, Otisi SK. Application of central composite design with design expert v13 in process optimization. In: Response surface methodology-research advances and applications. IntechOpen; 2023."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0170","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.colsurfb.2010.07.047","article-title":"Preparation and physicochemical characterization of naproxen\u2013PLGA nanoparticles","volume":"81","author":"Javadzadeh","year":"2010","journal-title":"Colloids Surf. B Biointerf."},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2025.114810_b0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.colsurfa.2009.04.006","article-title":"Development and characterization of liposomes containing glycols as carriers for diclofenac","volume":"342","author":"Manconi","year":"2009","journal-title":"Colloids Surf. A Physicochem. Eng. Asp"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114810_b0180","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s13346-023-01459-9","article-title":"Formulation, pharmacokinetics, and antibacterial activity of florfenicol-loaded niosome","volume":"14","author":"Abonashey","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114810_b0185","first-page":"101","article-title":"Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes","author":"Panwar","year":"2010","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0190","first-page":"122","article-title":"Optimizing and evaluating the transdermal permeation of hydrocortisone transfersomes formulation based on digital analysis of the in vitro drug release and ex vivo studies. recent advances in drug delivery and Formulation: formerly","volume":"16","author":"Abdelwahd","year":"2022","journal-title":"Recent Pat. Drug Deliv. Formul."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114810_b0195","first-page":"085","article-title":"Development and evaluation of sustained release matrix tablets of indapamide using Methocel K15M CR","volume":"3","author":"Hossain","year":"2013","journal-title":"J. Appl. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114810_b0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","article-title":"Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation","volume":"30","author":"Khallaf","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2025.114810_b0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.03.039","article-title":"Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats","volume":"254","author":"Mahmoud","year":"2017","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0210","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.xphs.2021.11.007","article-title":"Harnessing of doxylamine succinate\/pyridoxine hydrochloride-dual laden bilosomes as a novel combinatorial nanoparadigm for intranasal delivery: in vitro optimization and in vivo pharmacokinetic appraisal","volume":"111","author":"Salem","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114810_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-020-02790-3","article-title":"Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer","volume":"37","author":"Shukla","year":"2020","journal-title":"Pharm. Res."},{"issue":"16","key":"10.1016\/j.ejpb.2025.114810_b0220","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1039\/C5AY01207D","article-title":"A fast, sensitive, and high throughput method for the determination of nintedanib in mouse plasma by UPLC-MS\/MS","volume":"7","author":"Xu","year":"2015","journal-title":"Anal. Methods"},{"issue":"9","key":"10.1016\/j.ejpb.2025.114810_b0225","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.3390\/pharmaceutics15092242","article-title":"Formulation and therapeutic evaluation of isoxsuprine-loaded nanoparticles against diabetes-associated stroke","volume":"15","author":"Abou-Taleb","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S2221-1691(14)60231-8","article-title":"Acute and subacute oral toxicity study on the flavonoid rich fraction of Monodora tenuifolia seed in albino rats","volume":"4","author":"Ekeanyanwu","year":"2014","journal-title":"Asian Pac. J. Trop. Biomed."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114810_b0235","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3109\/03639045.2015.1107095","article-title":"Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids","volume":"42","author":"Yi","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2025.114810_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6673-3-26","article-title":"Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity","volume":"3","author":"Lachenmeier","year":"2008","journal-title":"J. Occup. Med. Toxicol."},{"issue":"10","key":"10.1016\/j.ejpb.2025.114810_b0245","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3390\/pharmaceutics13101633","article-title":"The impact of improving dermal permeation on the efficacy and targeting of liposome nanoparticles as a potential treatment for breast cancer","volume":"13","author":"Salem","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114810_b0250","doi-asserted-by":"crossref","DOI":"10.4103\/0975-8453.135837","article-title":"Invasomes-novel vesicular carriers for enhanced skin permeation","volume":"4","author":"Lakshmi","year":"2013","journal-title":"Syst. Rev. Pharm."},{"key":"10.1016\/j.ejpb.2025.114810_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121080","article-title":"Design of long acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia","volume":"608","author":"El-Tokhy","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114810_b0260","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1080\/10717544.2022.2072412","article-title":"Optimized 2-methoxyestradiol invasomes fortified with apamin: a promising approach for suppression of A549 lung cancer cells","volume":"29","author":"Awan","year":"2022","journal-title":"Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114810_b0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2015.03.020","article-title":"Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box\u2013Behnken design, in-vitro evaluation and in-vivo skin deposition study","volume":"485","author":"Abdelbary","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114810_b0270","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijbiomac.2012.07.030","article-title":"Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software","volume":"51","author":"Hooda","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2025.114810_b0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2016.03.030","article-title":"Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: in vitro characterization and in vivo pharmacokinetic assessment","volume":"505","author":"Kamran","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114810_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118657","article-title":"Development of an optimized avanafil-loaded invasomal transdermal film: ex vivo skin permeation and in vivo evaluation","volume":"570","author":"Ahmed","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114810_b0285","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2147\/IJN.S105016","article-title":"Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials","volume":"11","author":"Abdulbaqi","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0290","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1021\/mp500817h","article-title":"Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?","volume":"12","author":"Abouelmagd","year":"2015","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114810_b0295","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s13346-022-01148-z","article-title":"Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies","volume":"12","author":"Kala","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114810_b0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4274\/tjps.galenos.2018.34392","article-title":"Levocetirizine dihydrochloride-loaded chitosan nanoparticles: formulation and in vitro evaluation","volume":"17","author":"Kirimlio\u011flu","year":"2020","journal-title":"Turkish J. Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0305","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/scipharm89030033","article-title":"The optimization of a dimenhydrinate transdermal patch formulation based on the quantitative analysis of in vitro release data by DDSolver through skin penetration studies","volume":"89","author":"Abdul Rasool","year":"2021","journal-title":"Sci. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114810_b0310","first-page":"457","article-title":"Post market in vitro release profile study and cost comparison of different nicorandil brands available in Karachi, Pakistan","volume":"35","author":"Iffat","year":"2016","journal-title":"Lat. Am. J. Pharm"},{"issue":"6","key":"10.1016\/j.ejpb.2025.114810_b0315","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.3390\/molecules28062812","article-title":"Cytotoxicity against A549 human lung cancer cell line via the mitochondrial membrane potential and nuclear condensation effects of nepeta paulsenii briq., a perennial herb","volume":"28","author":"Hanif","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2025.114810_b0320","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jddst.2019.05.019","article-title":"Improved bioavailability of raloxifene hydrochloride using limonene containing transdermal nano-sized vesicles","volume":"52","author":"Waheed","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:40:11Z","timestamp":1762332011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125001870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"alternative-id":["S0939641125001870"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114810","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the efficacy of nintedanib-invasomes as a therapy for non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114810"}}